Skip to Main Content

Author Details

Per Artursson
Department of Pharmacy, Uppsala University
1983
238
77
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36868853Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.J Neurosci2023
37711184Proteome deconvolution of liver biopsies reveals hepatic cell composition as an important marker of fibrosis.Comput Struct Biotechnol J2023
37609337Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates.bioRxiv2023
36988826Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance.Clin Pharmacokinet2023
36690119Epithelial and microbial determinants of colonic drug distribution.Eur J Pharm Sci2023
34435745Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trial.Clin Transl Sci2022
35806468Hepatic Expression of the Na<sup>+</sup>-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation.Int J Mol Sci2022
35773367Professor Margareta Hammarlund-Udenaes - Humbled Scientist Shaping Modern Neuropharmacokinetics.Pharm Res2022
35648149Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.Eur J Clin Pharmacol2022
35404513Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.Br J Clin Pharmacol2022
36244560The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patients.Int J Pharm2022
35998570Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat.ACS Nano2022
36037309Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity.Clin Transl Sci2022
36087256Apoptosis Detection by Quantification of Cell Debris in Bright-Field Microscopy Images.Methods Mol Biol2022
36189884Monitoring drug-target interactions through target engagement-mediated amplification on arrays and in situ.Nucleic Acids Res2022
34891119Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration.Biomed Pharmacother2022
35158408Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity.Clin Pharmacol Ther2022
35089508High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3.Pharm Res2022
32970864Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight.Clin Pharmacol Ther2021
33739838Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes.Mol Pharm2021
33610694Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.Adv Drug Deliv Rev2021
34887943Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer.Ther Adv Med Oncol2021
34746700Conditions for maintenance of hepatocyte differentiation and function in 3D cultures.iScience2021
34321656Getting a grip with kirigami.Nat Mater2021
34233735Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis.J Exp Clin Cancer Res2021
33452735Hepatocyte size fractionation allows dissection of human liver zonation.J Cell Physiol2021
33159915Proteomics-Informed Identification of Luminal Targets For In Situ Diagnosis of Inflammatory Bowel Disease.J Pharm Sci2021
33007277Expanding the Efflux In Vitro Assay Toolbox: A CRISPR-Cas9 Edited MDCK Cell Line with Human BCRP and Completely Lacking Canine MDR1.J Pharm Sci2021
32161261Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy.Nat Commun2020
31937946A new opening for orally taken peptide drugs.Nat Biomed Eng2020
31685482A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity.Drug Metab Dispos2020
32743945The Critical Role of Passive Permeability in Designing Successful Drugs.ChemMedChem2020
32243721Cell-type-resolved proteomic analysis of the human liver.Liver Int2020
32344570Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug-Drug Interactions.Pharmaceutics2020
30560367A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes.Arch Toxicol2019
33575562Global variability analysis of mRNA and protein concentrations across and within human tissues.NAR Genom Bioinform2019
31701258A Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (f<sub>u,cell</sub>).Pharm Res2019
31214810Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies.AAPS J2019
31175671Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper.Clin Pharmacol Ther2019
31001971Image-Based Quantification of Cell Debris as a Measure of Apoptosis.Anal Chem2019
30971754Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations.Sci Rep2019
30336047Multiple-Enzyme-Digestion Strategy Improves Accuracy and Sensitivity of Label- and Standard-Free Absolute Quantification to a Level That Is Achievable by Analysis with Stable Isotope-Labeled Standard Spiking.J Proteome Res2019
29235598The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.Nanoscale2018
30126863CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box.Drug Metab Dispos2018
30442810Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation.Science2018
29386590Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound.Sci Rep2018
29709195Intracellular Drug Bioavailability: Effect of Neutral Lipids and Phospholipids.Mol Pharm2018
29301589Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.Genome Med2018
29343608Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates.Drug Metab Dispos2018
28709005Retraction Notice to: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule.Cell2017
  • 1 - 50 of 238

Recommended Authors

Gilead Sciences Inc.
Career Start Year 2014
Number of shared co-authors 7
Drug Metabolism and Pharmacokinetics
Career Start Year 2009
Number of shared co-authors 0
Schools of Pharmacy and Medicine, University of California san francisco
Career Start Year 2009
Number of shared co-authors 7
Translational Pharmaceutics Research Laboratory, Department of Pharmacy
Career Start Year 2008
Number of shared co-authors 0
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Career Start Year 2007
Number of shared co-authors 4
Stanford University
Career Start Year 2007
Number of shared co-authors 5
Amunix Pharmaceuticals
Career Start Year 2006
Number of shared co-authors 8
The Ohio State University
Career Start Year 2005
Number of shared co-authors 4
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade
Career Start Year 2004
Number of shared co-authors 0
Collegeville
Career Start Year 2004
Number of shared co-authors 6
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 0
Boston Children's Hospital, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 0
Shionogi & Co.
Career Start Year 1999
Number of shared co-authors 3
The Ohio State University
Career Start Year 1997
Number of shared co-authors 3
Washington State University
Career Start Year 1996
Number of shared co-authors 1
Ohio State University
Career Start Year 1994
Number of shared co-authors 5
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 8
Health Services and Systems Research, Duke-NUS Medical School
Career Start Year 1990
Number of shared co-authors 2
University Medical Center Hamburg-Eppendorf
Career Start Year 1989
Number of shared co-authors 0
Departamento de Toxicologia y Farmacologia Preclinica
Career Start Year 1989
Number of shared co-authors 0
University Hospital Munster
Career Start Year 1989
Number of shared co-authors 3
Novartis
Career Start Year 1988
Number of shared co-authors 0
Department of Pharmaceutical Sciences, Utrecht University
Career Start Year 1987
Number of shared co-authors 3
University of Turin
Career Start Year 1985
Number of shared co-authors 0
UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill
Career Start Year 1984
Number of shared co-authors 2
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 0
University of California san francisco
Career Start Year 1973
Number of shared co-authors 0
National Institutes of Health/National Institute of Environmental Health Sciences
Career Start Year 1971
Number of shared co-authors 0
Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences
Career Start Year 1969
Number of shared co-authors 1

Collaborators

University of Gothenburg
Co-authored papers 23
Western Human Nutrition Research Center
Co-authored papers 13
Unit for Pharmacokinetics and Drug Metabolism, University of Gothenburg
Co-authored papers 9
The University of Sheffield
Co-authored papers 8
Karolinska Institutet
Co-authored papers 8
Karolinska Institutet
Co-authored papers 8
Faculty of Pharmacy, University of Seville
Co-authored papers 4
Stockholm University
Co-authored papers 4
Stockholm University
Co-authored papers 4
Stockholm University
Co-authored papers 3
Uppsala University
Co-authored papers 3
Karolinska Institutet
Co-authored papers 3
Karolinska Institute
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Karolinska Institutet
Co-authored papers 2
Department of Pharmaceutical Biosciences, Uppsala University
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Umea University
Co-authored papers 2
Institute of Human Genetics, University Hospital Bonn
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Co-authored papers 1
Center for Biomedical Informatics, University of Tennessee Health Science Center
Co-authored papers 1
Co-authored papers 1
Howard Hughes Medical Institute
Co-authored papers 1
Western Human Nutrition Research Center
Co-authored papers 1
Bakar Computational Health Sciences Institute, University of California san francisco
Co-authored papers 1
Karolinska Institutet, BioClinicum J6
Co-authored papers 1
Department of Drug Metabolism and Pharmacokinetics, Inc.
Co-authored papers 1
and University of Tuebingen, University of Tuebingen
Co-authored papers 1